본문 바로가기
Ildong Holdings
Ildong Pharmaceutical
Ildong Bioscience
Ildong Hyaltech
Group Site
Yunovia
iLeadBMS
Idience
Aimsbioscience
Ethical Management
ENG
KOR
Company
Company
Company continuing to grow through positive changes and innovations
Greeting
About Us
Introduction
Philosophy/Vision
CI
History
Group Affiliates
Healthcare
Investing
Advertising
IT
Foundation
Compliance Program
Ethical Management
Introduction
Compliance Organization
Manufacturing Facilities
Introduction
Anseong Plant
Cheongju Plant
Consignment
NEWS
Location
Product
Product
Explore Ildong Pharmaceutical’s wide range of products.
Product Search
Finished Drugs(ETC)
Finished Drugs(OTC)
Raw Material Drugs
Health Supplements & Foods
Cosmetics
Medical Device
Others
Brand Stories
Aronamin
Biovita
Investor Information
Investor Information
Creating sustainable growth through transparent management
Share Information
Financial Information
Financial Status
IR
Disclosure Information
Notice
Financial Results
R&D
R&D
A vision-driven and value-generating global healthcare group
Strategy
Mission & Vision
R&D Strategy
Core Capabilities
Internal Organization
Ecosystem
Ildong Pharmaceutical
AIMS BioScience
Idience
iLEAD BMS
External Network
Pipeline
Global Business
Global Business
Welcomes all inquiries.
Status of Overseas Expansion
Business Model
UN SDGBI
Contact us
NEWS
Ildong Pharmaceutical’s latest developments and activities
Home
Company
NEWS
NEWS
Total Posts
23
All
Title
Contents
Search
Title, Registered On, Views table
NO
Title
Registered On
Views
23
ILDONG Pharmaceutical Participates in ‘CPhI Worldwide 2024'
2025.01.22
245
22
ILDONG Pharmaceutical Publishes 2024 Sustainability Management Report
2025.01.22
230
21
ILDONG Pharmaceutical Group Celebrates 83rd Anniversary
2025.01.22
219
20
‘Aronamin’ brand Ranks No. 1 in Korea Brand Power for 11 Consecutive Years
2025.01.22
244
19
ILDONG Pharmaceuticals Secures Patents for GLP-1 Drug Candidate in China and Japan
2025.01.22
240
18
ILDONG Pharmaceuticals’ Anseong Plant Acquires ISO 14001 Certification for Environmental Management System
2025.01.22
25
17
ILDONG Pharmaceuticals Participates in "BIO JAPAN" to Conduct Partnering Meetings
2025.01.22
25
16
ILDONG BioScience Receives FDA GRAS Certification for Probiotic Ingredients
2025.01.22
23
15
"Droptop Tab", a Cholesterol-Lowering Combination Drug, Expands into Indonesian Market!
2025.01.22
23
14
ILDONG Pharmaceutical Obtains U.S. Patent for New GLP-1RA Type 2 Diabetes Drug Candidate
2025.01.22
22
처음페이지
이전페이지
1
2
3
다음
마지막페이지